UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045613
Receipt number R000052076
Scientific Title Clinical trials on accommodation function of the eye by continuous intake of supplements. : A randomized, double blinded, placebo controlled, and parallel group comparison study.
Date of disclosure of the study information 2022/01/01
Last modified on 2023/04/06 09:22:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the supplement on accommodation of eye. : A randomized, double blinded, placebo controlled, and parallel group comparison study.

Acronym

Effect of the supplement on accommodation of eye.

Scientific Title

Clinical trials on accommodation function of the eye by continuous intake of supplements. : A randomized, double blinded, placebo controlled, and parallel group comparison study.

Scientific Title:Acronym

Clinical trials on accommodation function of the eye by continuous intake of supplements.

Region

Japan


Condition

Condition

Healthy volunteer

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of continuous ingestion of test foods on the accommodation function of the eye.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Accommodation of eye
Time: 0w, 4w

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Test Food Low dose
Intervention period:4weeks

Interventions/Control_2

Test Food High dose
Intervention period:4weeks

Interventions/Control_3

Placebo
Intervention period:4weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

45 years-old >

Gender

Male and Female

Key inclusion criteria

1. Japanese male or female between the ages of 30 and 45
2. Subjects who spend a lot of time working on VDT per day
3. Subjects who have no eye disease other than refractive error (myopia, hyperopia, astigmatism)
4. Subjects who fully understand the purpose and content of this test and agree in writing

Key exclusion criteria

1. Pollen allergies (during the study period) or perennial allergic conjunctivitis
2. LASIK surgery within 6 months
3. History or complication of serious liver, kidney, cardiovascular, gastrointestinal, lung, blood, or metabolic serious diseases
4. Regularly use medicines when obtaining consent
5. Cannot stop taking supplements during the test period
6. Have drug or food allergy
7. Participated in other clinical trials within the past month
8. Pregnant, breastfeeding or wish to become pregnant
9. Cannot maintain their daily habits
10. Have plans for overseas trips and long-term business trips
11. Shift workers and late-night workers who work after 0:00 AM
12. Users of supplements that may affect this test.
13. Drinker more than 40 g/day of pure alcohol
14. Smoker (over 20 cigarettes / day)
15. Who cannot take the test food as instructed
16. Donor of blood components or >= 200 mL whole blood within 1 month before the start of the test
17. Who feel sick after collecting blood
18. Determined by the responsible doctor to be inappropriate for this study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Yui

Organization

FANCL Corporation

Division name

Research Institute, Health science research center

Zip code

244-0806

Address

12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa, JAPAN

TEL

0458203443

Email

ke-yui@fancl.co.jp


Public contact

Name of contact person

1st name Yoshiki
Middle name
Last name Endoh

Organization

New drug research center, Inc.

Division name

Clinical Research Dept.

Zip code

061-1405

Address

452-1 Toiso, Eniwa-shi, Hokkaido, Japan

TEL

0123-34-0412

Homepage URL


Email

y-endoh@ndrcenter.co.jp


Sponsor or person

Institute

New Drug Research Center,Inc.

Institute

Department

Personal name



Funding Source

Organization

FANCL Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuhara Clinic Clinical Trial Review Committee

Address

Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido

Tel

0123-36-8029

Email

d-kameda@mediffom.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福原医院(北海道)


Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 08 Month 31 Day

Date of IRB

2021 Year 09 Month 07 Day

Anticipated trial start date

2021 Year 10 Month 02 Day

Last follow-up date

2021 Year 12 Month 05 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 09 Month 30 Day

Last modified on

2023 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052076